Evidence-based guide to combining melatonin with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction mechanisms, dose-separation windows, glucose monitoring, and clinical recommendations.
Evidence-based guide on combining NAC with CJC-1295 modified GRF. Covers interaction mechanisms, dose-separation windows, monitoring, and safety considerations.
St. John's Wort is a potent CYP3A4 inducer that may alter CJC-1295 metabolism. Learn the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to do if you already take both.
Evidence-based guide on combining vitamin B12 supplementation with CJC-1295 modified GRF, covering interaction risk, dose timing, monitoring, and clinical considerations.
Vitamin B12 and Prolia (denosumab) have no direct drug-supplement interaction. Learn why B12 monitoring still matters during osteoporosis treatment, especially if you also take metformin.
Vitamin D supplementation is recommended, not just safe, during Prolia (denosumab) therapy. Learn about dosing, monitoring, and why correcting vitamin D deficiency before starting denosumab matters.
Yes, vitamin B12 is safe to take with Trulicity (dulaglutide). No direct drug interaction exists. Learn why B12 monitoring matters on GLP-1 therapy, especially if you also take metformin.
Evidence-led guide on caffeine and dutasteride (Avodart) interactions. Covers metabolic pathways, blood pressure effects, BPH symptom overlap, and what remains unverified.
Evidence-based guide on combining glutathione supplements with dutasteride (Avodart). Covers pharmacokinetic interactions, liver metabolism concerns, dose-separation strategies, and monitoring recommendations.
Clinical review of combining glycine supplements with Avodart (dutasteride). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation guidance, monitoring, and safety data.
Evidence-based guide on combining omega-3 fatty acids (EPA/DHA) with dutasteride (Avodart). Covers pharmacokinetic and pharmacodynamic interactions, antiplatelet concerns, dose timing, monitoring, and clinical guidance.
Evidence-based guide to taking rhodiola rosea with Avodart (dutasteride). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation strategies, monitoring, and what to do if you already take both.
Dutasteride lowers DHT about 90%, while saw palmetto did not lower DHT or beat placebo for BPH in trials. No study tested them together.
Dutasteride is metabolized by CYP3A4 and St. John's wort induces CYP3A4, but no study of the combination was found. See what the Avodart label says.
A guide to taking zinc supplements alongside dutasteride (Avodart), covering pharmacodynamic interactions, copper depletion risk, dose timing, and monitoring recommendations.
Evidence-based guide on combining alpha-lipoic acid with Jardiance (empagliflozin). Covers interaction mechanisms, hypoglycemia risk, thyroid effects, dose-separation strategies, and monitoring recommendations.
What is known and not known about combining ashwagandha with Jardiance (empagliflozin): interaction mechanisms, blood sugar monitoring, thyroid considerations, and what to verify with a clinician or pharmacist.
Evidence-based guide to combining berberine with Jardiance (empagliflozin). Covers pharmacokinetic interactions, blood sugar risks, dose-separation strategies, and monitoring protocols.
Evidence-based guide to caffeine and enclomiphene citrate interactions, covering CYP1A2 metabolism, blood pressure effects, dose timing, and monitoring recommendations.
Evidence-based guide to combining CoQ10 (coenzyme Q10) with enclomiphene citrate. Covers interaction mechanisms, dose timing, monitoring, and safety data for men on fertility or hypogonadism therapy.
Evidence-based guide to the ginseng and enclomiphene citrate interaction, covering pharmacokinetic and pharmacodynamic concerns, dose-separation strategies, monitoring labs, and clinical recommendations.
Evidence-based review of glutathione and enclomiphene citrate co-administration, covering pharmacokinetic interactions, liver metabolism overlap, dose-separation guidance, and monitoring recommendations.
St. John's Wort is a potent enzyme inducer with hundreds of documented drug interactions. Here is what the evidence says about combining it with epitalon tetrapeptide, including mechanism analysis, monitoring steps, and dose-separation guidance.
A guide to the 5-HTP and oral estradiol interaction, covering serotonin pathway overlap, safety data, monitoring, and practical dosing guidance for menopausal women.
Evidence-based guide on ashwagandha and oral estradiol interactions, covering pharmacokinetic concerns, cortisol modulation, thyroid effects, dose-separation strategies, and monitoring recommendations.
Oral estradiol and caffeine both rely on the CYP1A2 liver enzyme. Here is what is established, what is pharmacologically plausible but unproven, and what a pharmacist or prescriber should verify before you change your coffee habits.
Calcium and oral estradiol are commonly used together during menopause. Learn about their interaction profile, absorption timing, cardiovascular considerations, and monitoring recommendations.
Clinical review of creatine supplementation during oral estradiol therapy for menopause. Covers interaction mechanism, creatinine monitoring, dose timing, renal safety, and what to tell your prescriber.
Evidence-based guide on combining NAC supplements with oral estradiol for menopause. Covers interaction mechanisms, dose-separation advice, monitoring, and clinical safety data.
The estradiol tablet label says St. John's wort may lower estrogen levels and change bleeding. See the CYP3A4 mechanism and what studies show.
Evidence-based guide on combining vitamin D supplements with oral estradiol (estrogen therapy). Covers interactions, dosing, bone health combination, and monitoring recommendations.
Evidence-based guide on taking folate with estradiol transdermal patches. Covers interaction mechanisms, MTHFR considerations, dosing, monitoring, and clinical recommendations.
Magnesium and estradiol patch (transdermal estradiol) have no known pharmacokinetic interaction. Learn about safety, dosing considerations, and monitoring when using both together.
Evidence-based guide on combining melatonin with the estradiol transdermal patch. Covers drug-supplement interactions, pharmacokinetic overlap, dose timing, monitoring, and clinical recommendations.
Clinical review of resveratrol and estradiol transdermal patch interactions, covering CYP3A4 metabolism, estrogenic activity, dose-separation guidance, and monitoring recommendations.
Clinical review of rhodiola rosea interactions with transdermal estradiol, covering pharmacokinetic and pharmacodynamic mechanisms, dose-separation strategies, and monitoring recommendations.
St. John's Wort induces CYP3A4 and can reduce estradiol levels from transdermal patches. Learn the mechanism, clinical evidence, monitoring steps, and safer alternatives.
Board-certified physicians explain whether vitamin D is safe to take with Lunesta (eszopiclone), covering pharmacokinetic data, dose-separation timing, monitoring labs, and what to tell your prescriber.
Evidence-based guide on combining magnesium supplements with Repatha (evolocumab). Covers interaction risk, dosing, monitoring, and what ASCVD patients should know.
Evidence-based review of ashwagandha and ezetimibe (Zetia) interactions, covering pharmacokinetic pathways, thyroid considerations, lipid effects, and clinical monitoring guidance.
Evidence-based guide to combining berberine with ezetimibe (Zetia). Covers CYP3A4 interaction risk, pharmacokinetic overlap, dose-separation strategy, lipid monitoring, and when to alert your prescriber.
Evidence-based guide on taking magnesium supplements with ezetimibe (Zetia). Covers pharmacokinetic data, dose-separation recommendations, monitoring, and cardiovascular benefits of co-administration.
Evidence-based guide on taking calcium supplements with finasteride. Covers interaction risk, dose-separation timing, absorption concerns, and monitoring recommendations.
Evidence-based guide on combining folate (folic acid, methylfolate) with finasteride for hair loss or BPH. Covers interactions, MTHFR considerations, dosing, and monitoring.
Evidence-based guide on combining glutathione supplements with finasteride for hair loss or BPH, covering drug interactions, safety data, dosing separation, and monitoring recommendations.
We found no study of L-theanine with finasteride, and the finasteride label lists no clinically important drug interactions. See what the evidence shows.
What the finasteride label says about interactions, whether melatonin is named, and why melatonin product content matters.
Evidence-based guide on combining quercetin and finasteride. Covers the plausible CYP3A4 interaction, what human data does and does not show, dose-separation strategies, and what to verify with a prescriber.
Evidence-based guide to the resveratrol and finasteride interaction, covering CYP3A4 pharmacokinetics, estrogenic overlap, dose-separation strategy, and monitoring recommendations.
The finasteride label reports no clinically important drug interactions and does not name vitamin D. Also covers vitamin D dose limits and side effects.
Can you take zinc with finasteride? Review the interaction information, elemental zinc amounts, copper effects and what the hair-loss studies actually tested.
Learn whether melatonin is safe to take with Addyi (flibanserin), including pharmacokinetic and pharmacodynamic considerations, dose-separation strategies, and monitoring recommendations.
GHK-Cu and creatine have no known direct pharmacologic interaction, but creatine raises serum creatinine, which can mask renal changes during copper peptide therapy. Here is what the evidence says about combining them safely.
Evidence-based guide to combining glycine supplements with GHK-Cu copper tripeptide. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation timing, collagen synthesis overlap, and monitoring recommendations.
Evidence-based guide on combining omega-3 fish oil (EPA/DHA) with copper tripeptide GHK-Cu. Covers interaction mechanisms, dose-separation windows, monitoring, and clinical safety data.
Evidence-based guide on combining resveratrol with GHK-Cu copper tripeptide. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, monitoring labs, and clinical guidance.
Evidence-based guide on combining vitamin B12 supplementation with GHK-Cu copper tripeptide. Covers interaction mechanisms, dose-separation timing, monitoring, and safety considerations.
Evidence-based guide on combining ashwagandha with Leqvio (inclisiran). Covers pharmacokinetic and pharmacodynamic interaction risks, dose-separation strategies, thyroid and cortisol monitoring, and clinical recommendations.
Evidence-based guide on combining glutathione supplements with Leqvio (inclisiran). Covers pharmacokinetic interactions, liver metabolism overlap, dose-separation guidance, and monitoring recommendations.
Evidence-based guide on combining magnesium supplements with Leqvio (inclisiran). Covers interaction risk, pharmacokinetic data, dosing guidance, and monitoring recommendations.